Synthesis of the novel PARP-1 inhibitor AG-690/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling (Q33759937)

29 July 2017

title

Synthesis of the novel PARP-1 inhibitor AG-690/11026014 and its protective effects on angiotensin II-induced mouse cardiac remodeling (English)

1 reference

29 July 2017

Guo-Shuai Feng

1

1 reference

29 July 2017

Cui-Ge Zhu

2

1 reference

29 July 2017

Zhuo-Ming Li

3

1 reference

29 July 2017

Pan-Xia Wang

4

1 reference

29 July 2017

Yi Huang

5

1 reference

29 July 2017

Min Liu

6

1 reference

29 July 2017

Ping He

7

1 reference

29 July 2017

Lan-Lan Lou

8

1 reference

29 July 2017

Shao-Rui Chen

9

1 reference

29 July 2017

Pei-Qing Liu

10

1 reference

29 July 2017

publication date

27 February 2017

1 reference

Acta Pharmacologica Sinica

29 July 2017

published in

1 reference

29 July 2017

volume

38

1 reference

29 July 2017

issue

5

1 reference

29 July 2017

page(s)

638-650

1 reference

Role of Sirtuins in Regulating Pathophysiology of the Heart

29 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

Protective effects of sirtuins in cardiovascular diseases: from bench to bedside

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

Poly(ADP-ribose) polymerase 1 (PARP1) in atherosclerosis: from molecular mechanisms to therapeutic implications

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

Regulation of myofibroblast differentiation by poly(ADP-ribose) polymerase 1

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

On PAR with PARP: cellular stress signaling through poly(ADP-ribose) and PARP-1.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

Sirtuin 6 protects cardiomyocytes from hypertrophy in vitro via inhibition of NF-κB-dependent transcriptional activity

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

PARP-1 inhibition increases mitochondrial metabolism through SIRT1 activation

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

SIRT1 promotes cell survival under stress by deacetylation-dependent deactivation of poly(ADP-ribose) polymerase 1

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

Angiotensin II promotes poly(ADP-ribosyl)ation of c-Jun/c-Fos in cardiac fibroblasts

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

Sirtuin functions in health and disease

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

Poly(ADP-ribose): novel functions for an old molecule

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

Mitochondrial poly(ADP-ribosylation): from old data to new perspectives.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

Angiotensin II blockade reverses myocardial fibrosis in a transgenic mouse model of human hypertrophic cardiomyopathy

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

Overexpression of angiotensin II type I receptor in cardiomyocytes induces cardiac hypertrophy and remodeling.

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system

14 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5457692

Protection from angiotensin II-induced cardiac hypertrophy and fibrosis by systemic lentiviral delivery of ACE2 in rats.

14 July 2018

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

PARP-1 suppresses adiponectin expression through poly(ADP-ribosyl)ation of PPAR gamma in cardiac fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

Activation of poly(ADP-ribose) polymerase contributes to development of doxorubicin-induced heart failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

PARP inhibition delays transition of hypertensive cardiopathy to heart failure in spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

PARP inhibition prevents postinfarction myocardial remodeling and heart failure via the protein kinase C/glycogen synthase kinase-3beta pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

Poly(ADP-Ribose) polymerase inhibition reduces reperfusion injury after heart transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

AG-690/11026014, a novel PARP-1 inhibitor, protects cardiomyocytes from AngII-induced hypertrophy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

Effect of 3-aminobenzamide, PARP inhibitor, on matrix metalloproteinase-9 level in plasma and brain of ischemic stroke model

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

Proteomic analysis of hypertrophied myocardial protein patterns in renovascularly hypertensive and spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

Intra-mitochondrial poly(ADP-ribosylation) contributes to NAD depletion and cell death induced by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

Inhibition of PARP prevents angiotensin II-induced aortic fibrosis in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

Resveratrol prevents the development of pathological cardiac hypertrophy and contractile dysfunction in the SHR without lowering blood pressure

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

Are poly(ADP-ribosyl)ation by PARP-1 and deacetylation by Sir2 linked?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

Angiotensin II type 2 receptor is essential for left ventricular hypertrophy and cardiac fibrosis in chronic angiotensin II-induced hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

7 January 2021

Possible role of poly(ADP-ribose) polymerase in pathological and physiological cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

7 January 2021

Poly(ADP-ribose) polymerase-1-deficient mice are protected from angiotensin II-induced cardiac hypertrophy

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

7 January 2021

Increased expression of poly(ADP-ribose) polymerase-1 contributes to caspase-independent myocyte cell death during heart failure

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

7 January 2021

Poly(ADP-ribose) polymerase-1 inhibitor 3-aminobenzamide enhances apoptosis induction by platinum complexes in cisplatin-resistant tumor cells

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

7 January 2021

SIRT1 activation attenuates diastolic dysfunction by reducing cardiac fibrosis in a model of anthracycline cardiomyopathy

1 reference

https://api.crossref.org/works/10.1038/APS.2016.159

7 January 2021

In vitro poly(ADP-ribosyl)ation of seminal ribonuclease

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28239158

12 December 2020

inferred from PubMed ID database lookup

Prevention of angiotensin II-induced cardiac remodeling by angiotensin-(1-7)

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28239158

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1038/APS.2016.159

1 reference

Dimensions Publication ID

29 July 2017

1084127657

0 references

Fatcat ID

release_bup7hlti6favnixqwh5pg2hawi

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/bup7hlti6favnixqwh5pg2hawi

24 November 2022

mapped directly with Wikidata item

PMC publication ID

5457692

1 reference

29 July 2017

1 reference